TY - JOUR
T1 - Dietary and/or physical activity interventions in women with overweight or obesity prior to fertility treatment
T2 - protocol for a systematic review and individual participant data meta-analysis
AU - Evans-Hoeker, Emily
AU - Wang, Zheng
AU - Groen, Henk
AU - Cantineau, Astrid E.P.
AU - Thurin-Kjellberg, Ann
AU - Bergh, Christina
AU - Laven, Joop S.E.
AU - Dietz De Loos, Alexandra
AU - Jiskoot, Geranne
AU - Baillargeon, Jean Patrice
AU - Palomba, Stefano
AU - Sim, Kyra
AU - Moran, Lisa J.
AU - Espinós, Juan J.
AU - Moholdt, Trine
AU - Rothberg, Amy E.
AU - Shoupe, Donna
AU - Hoek, Annemieke
AU - Legro, Richard S.
AU - Mol, Ben W.
AU - Wang, Rui
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022/11/7
Y1 - 2022/11/7
N2 - Introduction Dietary and/or physical activity interventions are often recommended for women with overweight or obesity as the first step prior to fertility treatment. However, randomised controlled trials (RCTs) so far have shown inconsistent results. Therefore, we propose this individual participant data meta-analysis (IPDMA) to evaluate the effectiveness and safety of dietary and/or physical activity interventions in women with infertility and overweight or obesity on reproductive, maternal and perinatal outcomes and to explore if there are subgroup(s) of women who benefit from each specific intervention or their combination (treatment-covariate interactions). Methods and analysis We will include RCTs with dietary and/or physical activity interventions as core interventions prior to fertility treatment in women with infertility and overweight or obesity. The primary outcome will be live birth. We will search MEDLINE, Embase, Cochrane Central Register of Controlled Trials and trial registries to identify eligible studies. We will approach authors of eligible trials to contribute individual participant data (IPD). We will perform risk of bias assessments according to the Risk of Bias 2 tool and a random-effects IPDMA. We will then explore treatment-covariate interactions for important participant-level characteristics. Ethics and dissemination Formal ethical approval for the project (Venus-IPD) was exempted by the medical ethics committee of the University Medical Center Groningen (METc code: 2021/563, date: 17 November 2021). Data transfer agreement will be obtained from each participating institute/hospital. Outcomes will be disseminated internationally through the collaborative group, conference presentations and peer-reviewed publication. PROSPERO registration number CRD42021266201.
AB - Introduction Dietary and/or physical activity interventions are often recommended for women with overweight or obesity as the first step prior to fertility treatment. However, randomised controlled trials (RCTs) so far have shown inconsistent results. Therefore, we propose this individual participant data meta-analysis (IPDMA) to evaluate the effectiveness and safety of dietary and/or physical activity interventions in women with infertility and overweight or obesity on reproductive, maternal and perinatal outcomes and to explore if there are subgroup(s) of women who benefit from each specific intervention or their combination (treatment-covariate interactions). Methods and analysis We will include RCTs with dietary and/or physical activity interventions as core interventions prior to fertility treatment in women with infertility and overweight or obesity. The primary outcome will be live birth. We will search MEDLINE, Embase, Cochrane Central Register of Controlled Trials and trial registries to identify eligible studies. We will approach authors of eligible trials to contribute individual participant data (IPD). We will perform risk of bias assessments according to the Risk of Bias 2 tool and a random-effects IPDMA. We will then explore treatment-covariate interactions for important participant-level characteristics. Ethics and dissemination Formal ethical approval for the project (Venus-IPD) was exempted by the medical ethics committee of the University Medical Center Groningen (METc code: 2021/563, date: 17 November 2021). Data transfer agreement will be obtained from each participating institute/hospital. Outcomes will be disseminated internationally through the collaborative group, conference presentations and peer-reviewed publication. PROSPERO registration number CRD42021266201.
UR - http://www.scopus.com/inward/record.url?scp=85141893791&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141893791&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2022-065206
DO - 10.1136/bmjopen-2022-065206
M3 - Review article
C2 - 36344004
AN - SCOPUS:85141893791
SN - 2044-6055
VL - 12
JO - BMJ open
JF - BMJ open
IS - 11
M1 - 065206
ER -